Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2

Experimental Neurology
Irina KiprianovaKlaus Unsicker

Abstract

FGF-2, a potent multifunctional and neurotrophic growth factor, is widely expressed in the brain and upregulated in cerebral ischemia. Previous studies have shown that intraventricularly or systemically administered FGF-2 reduces the size of cerebral infarcts. Whether endogenous FGF-2 is beneficial for the outcome of cerebral ischemia has not been investigated. We have used mice with a null mutation of the fgf2 gene to explore the relevance of endogenous FGF-2 in brain ischemia. Focal cerebral ischemia was produced by occlusion of the middle cerebral artery (MCAO). We found a 75% increase in infarct volume in fgf2 knock-out mice versus wild type littermates (P < 0.05). This difference in the extent of ischemic damage was observed after 24 h, and correlated with decreased viability in fgf2 mutant mice following MCA occlusion. Increased infarct volume in fgf2 null mice was associated with a loss of induction in hippocampal BDNF and trkB mRNA expression. These findings indicate that signaling through trkB may contribute to ameliorating brain damage following ischemia and that bdnf and trkB may be target genes of FGF-2. Together, our data provide the first evidence that endogenous FGF-2 is important in coping with ischemic brain da...Continue Reading

Citations

Oct 15, 2009·Journal of Neural Transmission·Ronen Robert LekerDavid Chernoguz
Oct 3, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·David A Greenberg, Kunlin Jin
Feb 8, 2008·Genes, Brain, and Behavior·K SchindowskiL Buée
May 13, 2014·BioMed Research International·Junying CaiYanhui Hu
Jul 27, 2005·Cell and Tissue Research·Oliver von Bohlen Und HalbachAlexei V Egorov
Jul 11, 2014·Expert Review of Neurotherapeutics·Bogusław Machalinski
Jan 25, 2007·Neurosurgery Clinics of North America·Robert J Dempsey, Haviryaji S G Kalluri
Sep 29, 2007·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Runjiang QuMichael Chopp
Mar 24, 2006·The European Journal of Neuroscience·S ZechelO von Bohlen und Halbach
Apr 25, 2006·Biological Psychiatry·Cortney A TurnerSimon J Evans
Feb 21, 2006·Experimental Neurology·Felix P EckensteinJason Deignan
Aug 17, 2014·The International Journal of Biochemistry & Cell Biology·Tobias D Merson, James A Bourne
Oct 14, 2008·Psychoneuroendocrinology·Venugopal Reddy VennaRégis Bordet
Dec 3, 2014·Biochemical and Biophysical Research Communications·Yong-Hua LiHong-Bin Yuan
Jun 29, 2010·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Sabrina ZechelOliver von Bohlen und Halbach
Nov 24, 2006·Stroke; a Journal of Cerebral Circulation·Ronen R LekerRonald D G McKay
Jan 13, 2018·Nature Reviews. Neuroscience·Mark P MattsonAiwu Cheng
Jul 6, 2019·Journal of Neuroendocrinology·Ruirui DongShigong Zhu
Oct 5, 2017·Biomolecules·Pratiek N MatkarKrishna K Singh
Aug 15, 2020·Neurochemical Research·Wanting LiYunman Li
Mar 20, 2018·Journal of Molecular Neuroscience : MN·Sara MilanizadehMohammad Reza Bigdeli
Apr 7, 2018·Neural Regeneration Research·Reggie H C LeeHung Wen Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
S YoshimuraMichael A Moskowitz
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
Takuji WatanabeShin-Ichi Miyatake
Proceedings of the National Academy of Sciences of the United States of America
Kunlin JinLisa M Ellerby
Cell and Tissue Research
Bernhard Reuss, Oliver von Bohlen und Halbach
© 2021 Meta ULC. All rights reserved